These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 36157118)

  • 1. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
    Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
    World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
    Sipeki N; Kovats PJ; Deutschmann C; Schierack P; Roggenbuck D; Papp M
    World J Gastroenterol; 2023 Nov; 29(42):5728-5750. PubMed ID: 38075846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Immunoglobulin G Autoantibody Against Malondialdehyde-Acetaldehyde Adducts as a Novel Serological Biomarker for Ulcerative Colitis.
    Duryee MJ; Ahmad R; Eichele DD; Hunter CD; Mitra A; Talmon GA; Singh S; Smith LM; Rosen MJ; Dhawan P; Thiele GM; Singh AB
    Clin Transl Gastroenterol; 2022 Apr; 13(4):e00469. PubMed ID: 35287144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures.
    Bourgonje AR; Andreu-Sánchez S; Vogl T; Hu S; Vich Vila A; Gacesa R; Leviatan S; Kurilshikov A; Klompus S; Kalka IN; van Dullemen HM; Weinberger A; Visschedijk MC; Festen EAM; Faber KN; Wijmenga C; Dijkstra G; Segal E; Fu J; Zhernakova A; Weersma RK
    Immunity; 2023 Jun; 56(6):1393-1409.e6. PubMed ID: 37164015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
    Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
    BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
    Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a novel antigen for Crohn's disease.
    Wei Y; Chen T; Yang W; Li H; Fang C; Liu Q; Chen Y; Mei Q
    Scand J Gastroenterol; 2021 Dec; 56(12):1427-1433. PubMed ID: 34487462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
    PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
    Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.
    Chen CS; Sullivan S; Anderson T; Tan AC; Alex PJ; Brant SR; Cuffari C; Bayless TM; Talor MV; Burek CL; Wang H; Li R; Datta LW; Wu Y; Winslow RL; Zhu H; Li X
    Mol Cell Proteomics; 2009 Aug; 8(8):1765-76. PubMed ID: 19357087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis.
    Marafini I; Laudisi F; Salvatori S; Lavigna D; Venuto C; Giannarelli D; Monteleone G
    Dig Liver Dis; 2024 Jan; 56(1):55-60. PubMed ID: 37407314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.
    Livanos AE; Dunn A; Fischer J; Ungaro RC; Turpin W; Lee SH; Rui S; Del Valle DM; Jougon JJ; Martinez-Delgado G; Riddle MS; Murray JA; Laird RM; Torres J; Agrawal M; Magee JS; Dervieux T; Gnjatic S; Sheppard D; Sands BE; Porter CK; Croitoru K; Petralia F; ; ; Colombel JF; Mehandru S
    Gastroenterology; 2023 Apr; 164(4):619-629. PubMed ID: 36634824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.